Caas Capital Management »

Verve Therapeutics shares owned by Caas Capital Management

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Caas Capital Management from 13F filings

Historical chart of Caas Capital Management investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by Caas Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by Caas Capital Management

Quarter filed Position value Share count Share price at filing
2022-12-31 $503k 26k 19.35
2021-09-30 $705k 15k 47.00
2021-06-30 $904k 15k 60.27

More positions owned by Caas Capital Management

Goldman Sachs Call Option (GS)
Microsoft Corporation (MSFT)
Kenvue (KVUE)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)
Morgan Stanley Com New Call Option (MS)
Amazon Call Option (AMZN)
Bank of America Corporation Call Option (BAC)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
Netflix Call Option (NFLX)
Lam Research Corporation Call Option (LRCX)
Chipotle Mexican Grill Call Option (CMG)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Qualcomm Call Option (QCOM)
Wells Fargo & Company Call Option (WFC)

View all positions for Caas Capital Management

Top funds holding Verve Therapeutics

Alphabet
ARK Investment Management
Vanguard Group
Federated Investors
Casdin Capital
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Jpmorgan Chase & Co
Arch Venture Corp
Redmile Group
Baker Bros. Advisors
EcoR1 Capital
BVF
Palo Alto Investors
Citadel Advisors

View all funds holding Verve Therapeutics